Building Confidence Through Analytical Validation

Every analytical testing and validation project begins with a detailed understanding of the product, intended use, target analyte, sample matrix, technology platform and stage of development. SNLS works with these requirements to design a structured study plan that defines the analytical parameters to be evaluated, the appropriate controls, sample concentrations, number of replicates and acceptance criteria.

The study design can be tailored for molecular assays, lateral flow devices, rapid diagnostic systems, nucleic-acid extraction kits, molecular reagents and other diagnostic prototypes. Depending on the product, the validation plan may include analytical sensitivity, specificity, limit of detection, inclusivity, exclusivity, cross-reactivity, interference, precision, reproducibility, robustness, matrix compatibility, linearity, analytical range and lot-to-lot consistency.

For molecular assays, study planning can also consider amplification efficiency, Ct consistency, extraction compatibility, internal-control performance and behavior at low target concentrations. For lateral flow and other visual assays, study design can focus on signal intensity, visual interpretation, sample flow, background, test-line consistency and performance near the detection threshold.

A clearly defined study plan helps ensure that the testing is relevant to the product and that the generated data can be interpreted consistently during subsequent development, optimization or technical review.

Once the study protocol is defined, the product is tested under controlled conditions to assess whether it performs consistently and according to the predefined criteria. Performance evaluation can be carried out using positive, negative and low-positive samples, reference materials, controls or suitable test panels depending on the technology and study objective.

Analytical sensitivity studies help determine how the assay behaves at progressively lower concentrations of the target. This can include dilution-series testing and repeated measurements near the expected detection limit. For molecular assays, Ct values, amplification curves and detection consistency can be evaluated, while lateral flow tests can be assessed for visible signal development, test-line intensity and interpretation consistency.

Specificity studies evaluate whether the assay responds selectively to the intended target. Where appropriate, this may include related organisms, non-target organisms, variants, serotypes or structurally similar analytes. Cross-reactivity and interference studies can also be used to identify substances or sample components that may affect assay performance.

Precision and reproducibility studies assess whether the test gives consistent results when repeated under the same or different conditions. This can include variation across operators, days, instruments, reagent preparations, test locations and manufacturing lots. Robustness studies can introduce small controlled variations in parameters such as sample volume, reaction time, incubation conditions or operating temperature to determine whether the assay remains stable within the expected working range.

Matrix compatibility can also be evaluated to understand whether different sample types influence detection, signal quality, recovery or interpretation. Where appropriate, comparative studies, linearity assessment, analytical range and invalid-rate analysis can also be included.

SNLS can support stability studies designed to understand how product performance is maintained during storage and use. Depending on the development requirement, this may include accelerated stability, real-time stability, open-vial stability or in-use stability evaluation.

During stability studies, predefined performance parameters are monitored at selected intervals to determine whether assay sensitivity, control performance, signal quality or other critical characteristics remain within acceptable limits.

Lot-to-lot evaluation can also be performed to compare independently manufactured batches. This helps assess whether changes in raw materials, reagent preparation or production conditions affect product performance and provides useful information for manufacturing scale-up and QC planning.

Analytical testing is supported by structured documentation to create a clear and traceable record of the study. The documentation package can include study protocols, test plans, acceptance criteria, sample and control information, raw-data worksheets, instrument records, observations, deviation records, result tables, statistical summaries and final analytical reports.

The final report summarizes the study design, methods, results and overall findings in a format that can support internal product review, further optimization, manufacturing decisions and technical documentation.

Where required, the analytical evidence can also be organized for use in subsequent quality, regulatory or product-development activities. The exact documentation provided can be adapted to the product type and project scope.

SNLS analytical testing and validation services can support a broad range of diagnostic technologies, including PCR, RT-PCR, RT-qPCR, multiplex molecular assays, lateral flow devices, rapid diagnostic kits, nucleic-acid extraction systems, molecular reagents, buffers and other diagnostic prototypes.

Each study is designed according to the specific technology rather than using a single generic validation format. This allows the performance parameters, testing conditions and documentation to remain relevant to the product being evaluated.

From Testing to the Next Development Stage

The purpose of analytical validation is not only to generate data, but also to identify how well the product performs and where further optimization may be required. The findings from testing can therefore guide assay refinement, formulation changes, manufacturing specifications, QC limits, stability planning and future validation activities.

By combining structured study planning, controlled testing and traceable documentation, SNLS helps diagnostic developers move from an early-stage prototype toward a more defined and development-ready product.